Aspire Biopharma Holdings (ASBP) EPS (Basic) Growth (1y) (2023 - 2026)
Aspire Biopharma Holdings (ASBP) EPS (Basic) Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 29.25% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 17,151.81% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 88.81% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Aspire Biopharma Holdings | 1.09 Mn | -733,865.14 | 5,750.00 | 95.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95.93% |
| Dec 31, 2025 | -526.24% |
| Sep 30, 2025 | -576.58% |
| Mar 31, 2025 | -311.64% |
| Dec 31, 2024 | -377.96% |
| Sep 30, 2024 | -173.08% |
| Jun 30, 2024 | -141.10% |
| Mar 31, 2024 | -529.44% |
| Dec 31, 2023 | -23.03% |
| Sep 30, 2023 | -108.04% |
| Jun 30, 2023 | 5,970.52% |
| Mar 31, 2023 | 1,467.60% |